...
首页> 外文期刊>The Journal of arthroplasty >The Use of Warfarin for DVT Prophylaxis Following Hip and Knee Arthroplasty: How Often Are Patients Within Their Target INR Range?
【24h】

The Use of Warfarin for DVT Prophylaxis Following Hip and Knee Arthroplasty: How Often Are Patients Within Their Target INR Range?

机译:华法林在髋关节和膝关节置换术后预防DVT的应用:患者多久处于目标INR范围内?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The purpose of this study was to determine the percentage of time that patients are therapeutic when prescribed warfarin for chemical thromboprophylaxis following a hip or knee arthroplasty procedure. One hundred eighty-four patients receiving warfarin for 4 weeks postoperatively, dosed using a Web-application accounting for patient demographics, INR levels, and concomitant medication use, were included. Patients with a target INR range between 1.7 and 2.7 were therapeutic for only 54.4% of the time (32.5% subtherapeutic, 13.0% supratherapeutic) while patients with a target INR range between 2.0 and 3.0 were therapeutic for only 45.9% of the time (39.2% subtherapeutic, 14.8% supratherapeutic). Patients receiving warfarin for chemical thromboprophylaxis are within their targeted INR range for only a limited period of time during their postoperative course. (C) 2014 Elsevier Inc. All rights reserved.
机译:这项研究的目的是确定髋关节或膝关节置换术后使用华法林进行化学性血栓预防的处方患者的治疗时间百分比。包括184名术后4周接受华法林的患者,这些患者使用Web应用程序进行剂量分配,以计算患者的人口统计信息,INR水平和伴随的药物使用情况。目标INR范围在1.7至2.7之间的患者仅在54.4%的时间内接受治疗(32.5%的亚治疗,13.0%的治疗疗法),而目标INR范围在2.0至3.0之间的患者仅在45.9%的时间内接受治疗(39.2亚治疗百分比,超治疗14.8%)。接受华法林化学血栓预防的患者在术后疗程中仅在有限的时间内处于目标INR范围内。 (C)2014 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号